Rocket


News + Filings
Transactions



Becker Daniel J.

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/09/2023ACELYRIN, Inc. Other (acquisition)Director Stock Option (right to buy)23.2k$18.00$418.4k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (disposition)Director Stock Option (right to buy)23.2k$18.00$418.4k 05/09/2023
05/09/2023ACELYRIN, Inc. PurchaseCommon Stock3k$18.00$54k 05/09/2023
05/04/2023ACELYRIN, Inc. GrantDirector Stock Option (right to buy)23.2k$18.00$418.4k 05/04/2023
06/21/2022Day One Biopharmaceuticals, Inc. GrantDirector Stock Option (Right to buy Common Stock)28.7k$16.29$467.5k 06/21/2022
06/01/2021Day One Biopharmaceuticals, Inc. PurchaseCommon Stock5k$16.00$80k 06/01/2021
05/26/2021Day One Biopharmaceuticals, Inc. GrantStock Option (right to buy Common Stock)63k$16.00$1M 06/01/2021
11/19/2020Pandion Therapeutics, Inc.PANDPurchaseCommon Stock197.7k$15.12$3MSee footnote11/19/2020
11/18/2020Pandion Therapeutics, Inc.PANDPurchaseCommon Stock14.2k$15.26$216.6kSee footnote11/17/2020
11/17/2020Pandion Therapeutics, Inc.PANDPurchaseCommon Stock2.2k$14.63$31.7kSee footnote11/17/2020
11/17/2020Pandion Therapeutics, Inc.PANDPurchaseCommon Stock13k$15.43$201kSee footnote11/17/2020
09/28/2020Principia Biopharma Inc.PRNBOtherCommon Stock667.6k$100.00$66.8MSee footnote09/28/2020
09/28/2020Principia Biopharma Inc.PRNBDispositionDirector Stock Option (right to buy)20.5k$17.00$348.1k 09/28/2020
09/28/2020Principia Biopharma Inc.PRNBDispositionDirector Stock Option (right to buy)10.2k$31.77$325.3k 09/28/2020
09/28/2020Principia Biopharma Inc.PRNBDispositionDirector Stock Option (right to buy)10.2k$62.66$641.6k 09/28/2020
07/21/2020Pandion Therapeutics, Inc.PANDConversionSeries B Preferred Stock9.6M$0.00$0See footnote07/17/2020
07/21/2020Pandion Therapeutics, Inc.PANDConversionCommon Stock1.9M$0.00$0See footnote07/17/2020
07/21/2020Pandion Therapeutics, Inc.PANDPurchaseCommon Stock722.2k$18.00$13MSee footnote07/17/2020
07/21/2020Pandion Therapeutics, Inc.PANDPurchaseCommon Stock1000$18.00$18k 07/17/2020
07/17/2020Pandion Therapeutics, Inc.PANDGrantStock Option (right to buy)14k$18.00$251.9k 07/17/2020
06/04/2020Principia Biopharma Inc.PRNBGrantDirector Stock Option (right to buy)10.2k$62.66$641.6k 06/04/2020
11/20/2019Principia Biopharma Inc.PRNBPurchaseCommon Stock55k$29.94$1.6MSee Footnote11/20/2019
10/29/2019Principia Biopharma Inc.PRNBPurchaseCommon Stock9.2k$33.98$312.5kSee Footnote10/28/2019
10/28/2019Principia Biopharma Inc.PRNBPurchaseCommon Stock68.4k$33.41$2.3MSee Footnote10/28/2019
10/18/2019Principia Biopharma Inc.PRNBPurchaseCommon Stock535k$28.00$15MSee Footnote10/18/2019
06/11/2019Principia Biopharma Inc.PRNBGrantDirector Stock Option (right to buy)10.2k$31.77$325.3k 06/11/2019
09/18/2018Principia Biopharma Inc.PRNBConversionCommon Stock1.1M$0.00$0See footnote09/18/2018
09/18/2018Principia Biopharma Inc.PRNBConversionCommon Stock312.7k$0.00$0See footnote09/18/2018
09/18/2018Principia Biopharma Inc.PRNBConversionCommon Stock260.6k$0.00$0See footnote09/18/2018
09/18/2018Principia Biopharma Inc.PRNBConversionCommon Stock544k$0.00$0See footnote09/18/2018
09/18/2018Principia Biopharma Inc.PRNBConversionCommon Stock167.5k$0.00$0See footnote09/18/2018
09/18/2018Principia Biopharma Inc.PRNBPurchaseCommon Stock270k$17.00$4.6MSee footnote09/18/2018
09/18/2018Principia Biopharma Inc.PRNBConversionSeries A Convertible Preferred Stock1.1M$0.00$0See footnote09/18/2018
09/18/2018Principia Biopharma Inc.PRNBConversionSeries B-1 Convertible Preferred Stock312.7k$0.00$0See footnote09/18/2018
09/18/2018Principia Biopharma Inc.PRNBConversionSeries B-2 Convertible Preferred Stock260.6k$0.00$0See footnote09/18/2018
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy